Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of the covid-19 pandemic on the (a) management and (b) outcomes of people with diabetes in (i) Fylde constituency and (ii) Lancashire.

Annual diabetes reviews are associated with reduced emergency admissions, amputations, retinopathy, and mortality. Following a significant decrease in routine care delivery that was associated with the pandemic, the proportion of people with type 1 diabetes receiving all eight care processes in England had recovered back to 43.3%, and 62.3% for type 2 diabetes, in 2023/24, compared to 27% and 37%, respectively, in 2020/21. Information has been provided at the national level as it is not available at the constituency level.

NHS England is supporting integrated care boards (ICBs), including Lancashire and South Cumbria ICB, to improve treatment and care for their populations and reduce variation by supporting systems’ awareness of national data and insights, through benchmarking and by promoting good practice. NHS England has provided £3 million of funding to systems to provide clinical leadership to ensure that clinical diabetes metrics, such as care processes and treatment targets, are reviewed at an ICB level, so that unwarranted variation can be identified. A resource hub of materials has been set up on Future NHS, which includes examples of innovation and best practice for the improvement of care process delivery, and for the achievement of treatment targets.